TrianglePUBLICATIONS · 12456509
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2003 Mar 15
- First author
- Segeren CM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Segeren CM
- type
- Author
- name
- Sonneveld P
- type
- Author
- name
- van der Holt B
- type
- Author
- name
- Vellenga E
- type
- Author
- name
- Croockewit AJ
- type
- Author
- name
- Verhoef GE
- type
- Author
- name
- Cornelissen JJ
- type
- Author
- name
- Schaafsma MR
- type
- Author
- name
- van Oers MH
- type
- Author
- name
- Wijermans PW
- type
- Author
- name
- Fibbe WE
- type
- Author
- name
- Wittebol S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Segeren CM
- type
- Author
- name
- Sonneveld P
- type
- Author
- name
- van der Holt B
- type
- Author
- name
- Vellenga E
- type
- Author
- name
- Croockewit AJ
- type
- Author
- name
- Verhoef GE
- type
- Author
- name
- Cornelissen JJ
- type
- Author
- name
- Schaafsma MR
- type
- Author
- name
- van Oers MH
- type
- Author
- name
- Wijermans PW
- type
- Author
- name
- Fibbe WE
- type
- Author
- name
- Wittebol S
- type
- Author
- bibliography ids
- nci-bib-092ec2e880b52aa1e995a29b
- book metadata
- content sha256
- 7d9d2b0f119ddb936720256779f6b2bddb8dc279bd9798c6e06d5ca01ccac63f
- document type
- citation
- dois
- 10.1182/blood-2002-03-0889
- electronic publication date
- display
- 2002 Nov 27
- precision
- day
- year
- 2002
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12456509
- immutable id
- pubmed:12456509@7d9d2b0f119ddb936720256779f6b2bddb8dc279bd9798c6e06d5ca01ccac63f
- journal
- abbreviation
- Blood
- issn electronic
- Source null
- issn print
- 0006-4971
- issue
- 6
- name
- Blood
- nlm unique id
- 7603509
- pages
- 2144-51
- volume
- 101
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 12456509
- provenance
- batch id
- 6646708a43dc2007bef0
- provider
- NCBI PubMed ESummary
- record sha256
- c270fbf9420970be3c2e4f1f22414986e4db7751837d66f68a2ba0040169114b
- response sha256
- 2e7ae6114dac3dd1eb0d8799c51ad362081554b4e07621e9ff80c0fb43c178c7
- retrieved at
- 2026-09-09T23:45:48.511831+00:00
- publication date
- display
- 2003 Mar 15
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study.
Preserved source evidence · Not medical advice